Quick Links

Author: Tina Taylor

The Bioanalytical Chemistry for Medicine and the Environment (BCME) Research Team at the University of Washington is currently recruiting study volunteers across the U.S. for a paid COVID-19 research. This study investigates early immune responses to COVID-19 right after infection, before symptoms develop, and follows...

Cannabis use disorder (CUD) is a significant and expanding health problem, and no FDA approved treatments are currently available. Persons with posttraumatic stress disorder (PTSD) may use cannabis to help control symptoms. Relief from PTSD insomnia, nightmares, anxiety, and preoccupying thoughts have been reported as...

To evaluate the efficacy of troriluzole as adjunctive therapy compared to placebo in subjects with OCD who have had an inadequate response to their current OCD treatment based on the change in their Y-BOCS score To assess the safety and tolerability of troriluzole, relative to placebo,...

To evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in patients with dementia of the Alzheimer's type To evaluate the effects of AVP-786 compared to placebo on neuropsychiatric symptoms To evaluate the effects of AVP-786 compared to placebo on...

To evaluate the clinical efficacy of ATH-1017 To determine the safety and tolerability of ATH-1017 To evaluate the clinical efficacy of ATH-1017 separately on: (1) cognition and (2) clinical global impression of change To evaluate the effect of ATH-1017 on activities of daily living To determine the plasma pharmacokinetic (PK) profile...

To assess the effect of donanemab versus placebo on clinical progression in participants with early symptomatic AD with demonstrated presence of tau pathology To assess the effect of donanemab versus placebo on clinical progression of participants with early symptomatic AD To assess the effect of donanemab versus...

SITE PARTNERS
uw-footer